Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients

Clinical trial NCT06203704 · COMPLETED

Trial details

NCT number: NCT06203704
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Kidney Disease (CKD)

Start date: 2023-12-20
Primary completion: 2025-09-30
Enrollment: 1086

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.